Nitrolingual (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitrolingual, is an organic nitrate presented as a sublingual tablet for sublingual use. It treats acute angina pectoris and is employed for prophylaxis of angina attacks in adult patients. By releasing nitric oxide, it produces vasodilation of coronary and peripheral vessels, lowering myocardial oxygen demand.

GNH USA supplies Nitrolingual as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑supported distribution across EU and other markets.

Nitrolingual (glyceryl trinitrate) is used in the management of coronary artery disease‑related conditions that cause chest pain. - Acute angina pectoris: provides rapid relief of chest pain by dilating coronary vessels and reducing cardiac workload. - Prophylaxis of angina attacks: decreases the frequency of episodes when taken before physical exertion or stress. - Stable angina: improves exercise tolerance by maintaining coronary blood flow during increased demand.

Glyceryl trinitrate may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Headache: throbbing pain caused by vasodilation. - Flushing: warmth and redness of the face or neck. - Dizziness: light‑headed sensation, especially on standing. Serious or Rare Side Effects: - Severe hypotension: marked blood pressure drop that may cause fainting. - Syncope: sudden loss of consciousness. - Methemoglobinemia: rare condition reducing oxygen transport in blood.

When prescribing glyceryl trinitrate, clinicians should observe several safety considerations to minimize risk. - Contraindicated in severe anemia: risk of inadequate oxygen delivery. - Avoid in hypotensive patients: may exacerbate low blood pressure. - Use caution with concurrent phosphodiesterase‑5 inhibitors: can cause profound vasodilation. - Monitor blood pressure regularly: ensure values remain within safe limits after dosing. - Educate patients on proper sublingual placement: tablet should dissolve under the tongue without swallowing. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Glyceryl trinitrate can interact with several medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of profound blood pressure fall. - Riociguat: synergistic vasodilation causing dangerous hypotension. Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory tachycardia, requiring blood pressure monitoring. - Calcium channel blockers: additive blood pressure lowering effect. - Antihypertensive agents (e.g., ACE inhibitors): may increase hypotensive risk. - Alcohol: can enhance vasodilatory response and dizziness.